Insider Stock Trading History of Iversen Leslie L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Iversen Leslie L since year 2005. The trader's CIK number is 1291623. At the time of this reporting, Iversen Leslie L is the of Acadia Pharmaceuticals Inc . (stock ticker symbol ACAD). See this page for all insider trading activities at Acadia Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Iversen Leslie L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-04-18 ACAD Acadia Pharmaceuticals Inc Option Ex 33,697 1.75 58,969
2016-04-18 ACAD Acadia Pharmaceuticals Inc Sale 33,697 33.53 1,129,995
2015-11-11 ACAD Acadia Pharmaceuticals Inc Option Ex 30,000 7.22 216,510
2015-11-11 ACAD Acadia Pharmaceuticals Inc Sale 30,000 36.01 1,080,330
2015-08-19 ACAD Acadia Pharmaceuticals Inc Option Ex 8,500 11.00 93,500
2015-08-19 ACAD Acadia Pharmaceuticals Inc Option Ex 8,500 11.00 93,500
2015-06-01 ACAD Acadia Pharmaceuticals Inc Option Ex 14,127 8.85 125,023
2014-01-02 ACAD Acadia Pharmaceuticals Inc Option Ex 60,000 1.87 112,380
2014-01-02 ACAD Acadia Pharmaceuticals Inc Sale 60,000 25.03 1,501,740
2013-09-12 ACAD Acadia Pharmaceuticals Inc Sale 60,000 22.92 1,375,440
2013-09-12 ACAD Acadia Pharmaceuticals Inc Option Ex 60,000 2.90 174,000
2013-02-21 ACAD Acadia Pharmaceuticals Inc Option Ex 4,500 .00 0
2009-05-18 ACAD Acadia Pharmaceuticals Inc Buy 3,000 1.65 4,950
2008-08-21 ACAD Acadia Pharmaceuticals Inc Option Ex 2,000 .00 0
2008-02-11 ACAD Acadia Pharmaceuticals Inc Option Ex 1,000 1.20 1,200
2006-12-11 ACAD Acadia Pharmaceuticals Inc Option Ex 3,000 .50 1,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Iversen Leslie L ( of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.